AnalystsWilliam Pickering
William Pickering's Stock Forecasts

Analyst Ranking
Bottom 12%
#4751 out of 5334 analysts
Average Return
-2.64%
Win Rate
50%12 out of 24
Risk vs Reward
Poor
Good

William Pickering's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Alnylam Pharmaceuticals IncALNY
+72.24%$235.95$406.40
2025-01-07 -
2026-01-06
Buy
Vertex Pharmaceuticals IncVRTX
+41.12%$358.40$505.78
2023-08-02 -
2024-08-01
Buy
Vertex Pharmaceuticals IncVRTX
+39.88%$354.05$495.26
2023-07-28 -
2024-07-26
Buy
Vertex Pharmaceuticals IncVRTX
+36.16%$302.66$412.11
2023-03-21 -
2024-03-20
Buy
Vertex Pharmaceuticals IncVRTX
+15.53%$346.36$400.16
2023-05-03 -
2024-05-02
Buy

William Pickering Analyst Color

Get additional color on William Pickering's coverage of popular stocks

William Pickering's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Intellia Therapeutics IncNTLA
3Hold$17.00+58.43%Maintains
2 months ago
Dyne Therapeutics IncDYN
1Hold$24.00-1.80%Maintains
2 months ago
Crispr Therapeutics AgCRSP
2Hold$56.00+20.33%Maintains
2 months ago
Beam Therapeutics IncBEAM
3Buy$39.00+55.38%Maintains
2 months ago
Arrowhead Pharmaceuticals IncARWR
3Hold$46.00-46.26%Maintains
2 months ago
Biomarin Pharmaceutical IncBMRN
7Buy$82.00+38.21%Maintains
3 months ago
Vertex Pharmaceuticals IncVRTX
5Buy$572.00+19.83%Maintains
3 months ago
Allogene Therapeutics IncALLO
3Hold$3.85+121.26%Maintains
3 months ago
Regeneron Pharmaceuticals IncREGN
4Buy$921.00+40.39%Maintains
4 months ago
Bridgebio Pharma IncBBIO
1Buy$94.00+11.88%Initiates Coverage On
8 months ago
Biohaven LtdBHVN
3Hold$9.00-37.15%Downgrades
9 months ago
Biogen IncBIIB
1Hold$157.00-22.35%Maintains
9 months ago
Avidity Biosciences IncRNAM
1Hold$72.00+388.14%Downgrades
9 months ago
Sarepta Therapeutics IncSRPT
1Hold$13.00-17.09%Initiates Coverage On
a year ago
Alnylam Pharmaceuticals IncALNY
2Buy$310.00N/AMaintains
2 years ago
Ionis Pharmaceuticals IncIONS
1Sell$31.00N/AInitiates Coverage On
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.